Study, 2011
How does pharmaceutical company marketing affect who gets diagnosed with PMDD?
This article examines how drug companies market PMDD to the public and shows how marketing affects diagnosis and treatment decisions.
What they did
Analyzed pharmaceutical company marketing campaigns that were marketed directly to the public, particularly looking at self-diagnosis tools and symptom checklists.
What they found
The marketing campaigns use self-diagnosis tools designed to turn people into patients seeking a PMDD diagnosis and the company's branded drug. Marketing campaigns influence how diseases are defined and who gets diagnosed in ways that benefit the drug company.
What it means for you
This is a social and business analysis of how diseases get defined and marketed to patients. It's not a medical study testing whether a treatment works. This shows that some diagnosis definitions in healthcare are influenced by business interests, not only by medical science.
About the study
- Original title
- 'Get with the Program!': pharmaceutical marketing, symptom checklists and self-diagnosis
- Authors
- Ebeling M
- Journal
- Social science & medicine (1982)
- Year
- 2011
- Study design
- Study
- What was tested
- Marketing campaigns and self-diagnosis tools
- Read the paper
- doi.org/10.1016/j.socscimed.2011.05.054
Topics
Related studies
Cohort study, 2026
What genetic factors are linked to premenstrual symptoms?
Review, 2026
How well do SSRIs treat PMS?
Systematic review, 2026
How often do mood disorders and PMS or PMDD occur together?
Systematic review, 2026
Are hormone levels different in women with PMS?
Systematic review, 2026
Does vitamin D supplementation help PMS symptoms?
Study, 2026
How do women with PMDD process emotions differently in their brains?